ABSTRACT

With a total of 135,033 lung cancer deaths occurring annually due to cigarette smoking, including secondhand smoke exposure, interventions that target smoking habits or early detection through low-dose computed tomographic screening for lung cancer can thus serve an influential role in decreasing lung cancer burden. Therefore, as lung cancer screening programs are developed, partnerships with existing tobacco cessation programs or incorporation of these cessation services can offer a unique avenue for decreasing lung cancer mortality. This chapter discusses the impact of smoking cessation on lung cancer burden and the evidence supporting the addition of smoking cessations interventions to lung cancer screening programs and reviews approaches for implementation and potential barriers, including the additive value of the role of nonphysician clinicians to the process.